{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:16:34Z","timestamp":1792793794462,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,12]]},"DOI":"10.7759\/cureus.87786","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T17:53:52Z","timestamp":1752342832000},"source":"Crossref","is-referenced-by-count":3,"title":["Predicting Bone Metastasis in Prostate Cancer Patients Using Total Serum Prostate-Specific Antigen and Serum Alkaline Phosphatase: Model Development, Validation, and Deployment as a Digital Risk Estimator"],"prefix":"10.7759","author":[{"given":"Frank","family":"Obeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Yawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nii-Boye","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvester A","family":"Boakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banabas","family":"Kpankyaano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Appiateng W","family":"Boadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evans  K","family":"Zikpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justice","family":"Dzomeku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic A","family":"Dankwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.04.017","article-title":"High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer","volume":"192","author":"Hsing AW","year":"2014","unstructured":"Hsing AW, Yeboah E, Biritwum R, et al.. High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer. J Urol. 2014, 192:730-5. 10.1016\/j.juro.2014.04.017","journal-title":"J Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5114\/jcb.2016.62972","article-title":"Prostate brachytherapy in Ghana: our initial experience","volume":"8","author":"Mensah JE","year":"2016","unstructured":"Mensah JE, Yarney J, Vanderpuye V, Akpakli E, Tagoe S, Sasu E. Prostate brachytherapy in Ghana: our initial experience. J Contemp Brachytherapy. 2016, 8:379-85. 10.5114\/jcb.2016.62972","journal-title":"J Contemp Brachytherapy"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003452","article-title":"Updates to Advanced Prostate Cancer: AUA\/SUO Guideline (2023)","volume":"209","author":"Lowrance W","year":"2023","unstructured":"Lowrance W, Dreicer R, Jarrard DF, et al.. Updates to Advanced Prostate Cancer: AUA\/SUO Guideline (2023). J Urol. 2023, 209:1082-90. 10.1097\/JU.0000000000003452","journal-title":"J Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-362","article-title":"Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry","volume":"14","author":"Laryea DO","year":"2014","unstructured":"Laryea DO, Awuah B, Amoako YA, et al.. Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry. BMC Cancer. 2014, 14:362. 10.1186\/1471-2407-14-362","journal-title":"BMC Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2741\/1891","article-title":"Prostate cancer epidemiology","volume":"11","author":"Hsing AW","year":"2006","unstructured":"Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci. 2006, 11:1388-413. 10.2741\/1891","journal-title":"Front Biosci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4314\/wajm.v23i2.28104","article-title":"A review of genitourinary cancers at the Korle-Bu teaching hospital Accra, Ghana","volume":"23","author":"Klufio GO","year":"2004","unstructured":"Klufio GO. A review of genitourinary cancers at the Korle-Bu teaching hospital Accra, Ghana. West Afr J Med. 2004, 23:131-4. 10.4314\/wajm.v23i2.28104","journal-title":"West Afr J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-6-159","article-title":"Cancer mortality patterns in Ghana: a 10-year review of autopsies and hospital mortality","volume":"6","author":"Wiredu EK","year":"2006","unstructured":"Wiredu EK, Armah HB. Cancer mortality patterns in Ghana: a 10-year review of autopsies and hospital mortality. BMC Public Health. 2006, 6:159. 10.1186\/1471-2458-6-159","journal-title":"BMC Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-55382010000600006","article-title":"Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study","volume":"36","author":"Al-Ghazo MA","year":"2010","unstructured":"Al-Ghazo MA, Ghalayini IF, Al-Azab RS, Bani-Hani I, Barham A, Haddad Y. Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study. Int Braz J Urol. 2010, 36:685-91; discussion 691-2. 10.1590\/s1677-55382010000600006","journal-title":"Int Braz J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.prnil.2015.02.006","article-title":"Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels","volume":"3","author":"Koo KC","year":"2015","unstructured":"Koo KC, Park SU, Kim KH, Rha KH, Hong SJ, Yang SC, Chung BH. Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels. Prostate Int. 2015, 3:10-5. 10.1016\/j.prnil.2015.02.006","journal-title":"Prostate Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.afju.2016.10.003","article-title":"Prostate cancer revealed by skin metastasis: a case report in black African man","volume":"204","author":"Tengue KT","year":"2017","unstructured":"Tengue KT, Kpatchaa E, Sewaa K, et al.. Prostate cancer revealed by skin metastasis: a case report in black African man. Afr J Urol. 2017, 204:7. 10.1016\/j.afju.2016.10.003","journal-title":"Afr J Urol"},{"key":"ref11","article-title":"Metastasis on bone scan with low prostate specific antigen (\u226420 ng\/ml) and Gleason's score (<8) in newly diagnosed Pakistani males with prostate cancer: should we follow Western guidelines?","volume":"12","author":"Zaman MU","year":"2011","unstructured":"Zaman MU, Fatima N, Sajjad Z. Metastasis on bone scan with low prostate specific antigen (\u226420 ng\/ml) and Gleason's score (<8) in newly diagnosed Pakistani males with prostate cancer: should we follow Western guidelines?. Asian Pac J Cancer Prev. 2011, 12:1529-32.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet N","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M, et al.. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017, 71:618-29. 10.1016\/j.eururo.2016.08.003","journal-title":"Eur Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4314\/aas.v15i1.2","article-title":"Can PSA predict bone metastasis amongst newly diagnosed cancer of the prostate?","volume":"1","author":"Ojuka D","year":"2018","unstructured":"Ojuka D, Majicha S, Ngugyi P. Can PSA predict bone metastasis amongst newly diagnosed cancer of the prostate?. Ann Afr Surg. 2018, 1:4-7. 10.4314\/aas.v15i1.2","journal-title":"Ann Afr Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.273","article-title":"Ethnic differences in prostate cancer","volume":"105","author":"Kheirandish P","year":"2011","unstructured":"Kheirandish P, Chinegwundoh F. Ethnic differences in prostate cancer. Br J Cancer. 2011, 105:481-5. 10.1038\/bjc.2011.273","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-014-1903-9","article-title":"Comparison of choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis","volume":"43","author":"Shen G","year":"2014","unstructured":"Shen G, Deng H, Hu S, Jia Z. Comparison of choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol. 2014, 43:1503-13. 10.1007\/s00256-014-1903-9","journal-title":"Skeletal Radiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/0972-3919.110683","article-title":"Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy","volume":"27","author":"Kamaleshwaran KK","year":"2012","unstructured":"Kamaleshwaran KK, Mittal BR, Harisankar CN, Bhattacharya A, Singh SK, Mandal AK. Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy. Indian J Nucl Med. 2012, 27:81-4. 10.4103\/0972-3919.110683","journal-title":"Indian J Nucl Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/79184355","article-title":"Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients","volume":"85","author":"McArthur C","year":"2012","unstructured":"McArthur C, McLaughlin G, Meddings RN. Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients. Br J Radiol. 2012, 85:390-4. 10.1259\/bjr\/79184355","journal-title":"Br J Radiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2014.0741","article-title":"The diagnostic imaging of bone metastases","volume":"111","author":"Heindel W","year":"2014","unstructured":"Heindel W, G\u00fcbitz R, Vieth V, Weckesser M, Schober O, Sch\u00e4fers M. The diagnostic imaging of bone metastases. Dtsch Arztebl Int. 2014, 111:741-7. 10.3238\/arztebl.2014.0741","journal-title":"Dtsch Arztebl Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2011.01.018","article-title":"Clinicopathologic features and determinants of Gleason score of prostate cancer in Ghanaian men","volume":"31","author":"Yarney J","year":"2013","unstructured":"Yarney J, Vanderpuye V, Mensah J. Clinicopathologic features and determinants of Gleason score of prostate cancer in Ghanaian men. Urol Oncol. 2013, 31:325-30. 10.1016\/j.urolonc.2011.01.018","journal-title":"Urol Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx235","article-title":"TMPRSS2:ERG gene fusions in prostate cancer of West African men and a meta-analysis of racial differences","volume":"186","author":"Zhou CK","year":"2017","unstructured":"Zhou CK, Young D, Yeboah ED, et al.. TMPRSS2:ERG gene fusions in prostate cancer of West African men and a meta-analysis of racial differences. Am J Epidemiol. 2017, 186:1352-61. 10.1093\/aje\/kwx235","journal-title":"Am J Epidemiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.17.00234","article-title":"Contemporary radiation treatment of prostate cancer in Africa: a Ghanaian experience","volume":"4","author":"Asamoah FA","year":"2018","unstructured":"Asamoah FA, Yarney J, Awasthi S, et al.. Contemporary radiation treatment of prostate cancer in Africa: a Ghanaian experience. J Glob Oncol. 2018, 4:1-13. 10.1200\/JGO.17.00234","journal-title":"J Glob Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S1016-3190(08)60053-1","article-title":"Predicting bone metastasis in prostate cancer patients: value of prostate specific antigen","volume":"21","author":"Wei L","year":"2009","unstructured":"Wei L, Chiu J, Chang S, et al.. Predicting bone metastasis in prostate cancer patients: value of prostate specific antigen. Tzu Chi Med J. 2009, 21:291-5. 10.1016\/S1016-3190(08)60053-1","journal-title":"Tzu Chi Med J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-013-0408-y","article-title":"Alkaline phosphatase: an overview","volume":"29","author":"Sharma U","year":"2014","unstructured":"Sharma U, Pal D, Prasad R. Alkaline phosphatase: an overview. Indian J Clin Biochem. 2014, 29:269-78. 10.1007\/s12291-013-0408-y","journal-title":"Indian J Clin Biochem"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s001120050054","article-title":"Determination of bone-specific alkaline phosphatase in disorders of calcium metabolism in childhood","volume":"144","author":"Reiss I","year":"1996","unstructured":"Reiss I, Inderrieden D, Kruse K. Determination of bone-specific alkaline phosphatase in disorders of calcium metabolism in childhood. Monatsschr Kinderheilkd. 1996, 144:885-90. 10.1007\/s001120050054","journal-title":"Monatsschr Kinderheilkd"},{"key":"ref25","article-title":"EAU Guidelines on Prostate Cancer 2023","author":"European Association of Urology","year":"2023","unstructured":"European Association of Urology. EAU Guidelines on Prostate Cancer 2023. European Association of Urology, Arnhem, The Netherlands; 2023."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hym097","article-title":"Bone scanning--who needs it among patients with newly diagnosed prostate cancer?","volume":"37","author":"Hirobe M","year":"2007","unstructured":"Hirobe M, Takahashi A, Hisasue S, et al.. Bone scanning--who needs it among patients with newly diagnosed prostate cancer?. Jpn J Clin Oncol. 2007, 37:788-92. 10.1093\/jjco\/hym097","journal-title":"Jpn J Clin Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/wjnm.wjnm_129_20","article-title":"Prostate-specific antigen for prediction of skeletal metastases on bone scintigraphy in prostate cancer","volume":"20","author":"Hammond EN","year":"2021","unstructured":"Hammond EN, Amoako YA, Laryea DO, Amoah G. Prostate-specific antigen for prediction of skeletal metastases on bone scintigraphy in prostate cancer. World J Nucl Med. 2021, 20:327-8. 10.4103\/wjnm.wjnm_129_20","journal-title":"World J Nucl Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.19627.45606","article-title":"Predicting Bone Metastasis in prostate Cancer Patients Using Total Serum Prostate-Specific Antigen (PSA) and Serum Alkaline Phosphatase (ALP)\u2014A Study at the Korle-Bu Teaching Hospital, Accra [Thesis]","author":"Obeng F","year":"2024","unstructured":"Obeng F. Predicting Bone Metastasis in prostate Cancer Patients Using Total Serum Prostate-Specific Antigen (PSA) and Serum Alkaline Phosphatase (ALP)\u2014A Study at the Korle-Bu Teaching Hospital, Accra [Thesis]. Faculty of Surgery (Urology), Ghana College of Surgeons, Accra, Ghana; 2024. 10.13140\/RG.2.2.19627.45606"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.09.007","article-title":"External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination","volume":"68","author":"Siontis GC","year":"2015","unstructured":"Siontis GC, Tzoulaki I, Castaldi PJ, Ioannidis JP. External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. J Clin Epidemiol. 2015, 68:25-34. 10.1016\/j.jclinepi.2014.09.007","journal-title":"J Clin Epidemiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-77244-8","article-title":"Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating","author":"Steyerberg EW","year":"2010","unstructured":"Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. Springer, New York; 2010. 10.1007\/978-0-387-77244-8"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382086-predicting-bone-metastasis-in-prostate-cancer-patients-using-total-serum-prostate-specific-antigen-and-serum-alkaline-phosphatase-model-development-validation-and-deployment-as-a-digital-risk-estimator","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T17:53:54Z","timestamp":1752342834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382086-predicting-bone-metastasis-in-prostate-cancer-patients-using-total-serum-prostate-specific-antigen-and-serum-alkaline-phosphatase-model-development-validation-and-deployment-as-a-digital-risk-estimator"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.87786","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,12]]}}}